|
|
||||||||
From the
1 From the Department of Microbiology and Public Health, Michigan State University, East Lansing, Michigan, 48823
The interaction between human Clq and immunoglobulins was measured quantitatively by determining the ability of IgG, IgM, and (Fc)5µ to inhibit the binding of 125I-labeled Clq to IgM covalently linked to cyanogen bromide activated Sepharose. The following inhibition constants were determined: Ki for IgM = 6.42 x 10-6 m; Ki for (Fc)5µ = 4.35 x 10-6 m; and Ki for IgG = 1.10 x 10-4 m. The heat aggregation of IgM and IgG increased the ability of these proteins to bind 125I-labeled Clq, but had no significant effect on the binding properties of (Fc)5µ. The binding between the 125I-labeled Clq and the IgM-Sepharose complex was inhibitable with aromatic and alkyl diamino compounds. The most potent inhibitor was 2,5-diaminotoluene.
Binding Properties of the Human Complement Protein Clq
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains J. Immunol., July 15, 2003; 171(2): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kishore, P. Strong, M. V. Perdikoulis, and K. B. M. Reid A Recombinant Homotrimer, Composed of the {{alpha}} Helical Neck Region of Human Surfactant Protein D and C1q B Chain Globular Domain, Is an Inhibitor of the Classical Complement Pathway J. Immunol., January 1, 2001; 166(1): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |